Login / Signup

Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies.

Philippe NicolasHugo Marion-MoffetMorgane GossezSandra VukusicGuillaume MonneretRomain MarignierFabienne Venet
Published in: Journal of neurology (2022)
Keyphrases
  • sars cov
  • multiple sclerosis
  • immune response
  • respiratory syndrome coronavirus
  • coronavirus disease